To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case-control analysis, in primary care.

Francesco LapiEttore MarconiIgnazio GrattaglianoAlessandro RossiDiego FornasariAlberto MagniPierangelo Lora AprileClaudio Cricelli

Published in: Internal and emergency medicine (2022)

Our findings provide reassuring evidence on the use and safety profile of paracetamol to treat early symptoms of COVID-19 as in other respiratory infections.

Keyphrases

case control
primary care
coronavirus disease
sars cov
anti inflammatory drugs
general practice